Skip to main content

4DMedical Signs Distribution Agreement with Blackford

Melbourne, Australia, 26 February 2024: Respiratory imaging technology company 4DMedical Limited (ASX:4DX, “4DMedical”, or the “Company”) today announces the signing of an agreement with Blackford Analysis Inc (“Blackford” or “the Blackford Platform™”) to distribute Imbio’s medical imaging AI solutions.

Medical imaging AI marketplaces like the Blackford Platform™ are an important part of the medical AI ecosystem, as many hospital radiology departments prefer to purchase a wide array of AI solutions through a one-stop-shop rather than dealing with the commercial, legal and technical complexity of multiple individual providers.

The Blackford Platform™ is a medical imaging AI marketplace that is recognised as a global industry leader in consolidating disparate AI clinical applications. The platform provides access to AI technologies through integration, workflow, orchestration, and reporting, and will now host the Imbio product portfolio.